Device type · JIR
Indicator Method, Protein Or Albumin (Urinary, Non-Quant.)
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
JIR
Clinical Chemistry
Device class
Class I
FDA decisions since 2015
3
510(k), De Novo and PMA
Adverse event reports
9
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Indicator Method, Protein Or Albumin (Urinary, Non-Quant.)
- Product code
- JIR
- Device class
- Class I
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1645
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for JIR
Latest FDA decisions
- Minuteful-kidney test510(k)
K222921 · Decided Sep 8, 2023 · 347 days after receipt
Device type: Indicator Method, Protein Or Albumin (Urinary, Non-Quant.) (JIR) · Laboratory Medicine & Pathology
- Minuteful - kidney test510(k)
K210069 · Decided Jul 6, 2022 · 541 days after receipt
Device type: Indicator Method, Protein Or Albumin (Urinary, Non-Quant.) (JIR) · Laboratory Medicine & Pathology
K150330 · Decided Apr 30, 2015 · 79 days after receipt
Device type: Indicator Method, Protein Or Albumin (Urinary, Non-Quant.) (JIR) · Laboratory Medicine & Pathology
Reports received
9
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
9
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 3 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 1 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 1 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 1 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 1 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 7 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Incorrect, Inadequate or Imprecise Result or Readings4
- False Positive Result3
- Low Test Results1
1 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions9
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Atellica CH Urine Albumin REF: 11537225, in vitro diagnosticOpen, Classified
Siemens Healthcare Diagnostics, Inc.
Z-2890-2026 · Started Jul 6, 2026 · Posted by FDA Aug 5, 2026
Reason given: Processing of urine albumin assay on the CI analyzers may lead to the following issues: Falsely depressed Atellica CH Urea Nitrogen (UN_c) results; Falsely depressed Atellica CH Enzymatic Hemoglobin A1c (A1c_E) results; Increased rate of reaction cuvette QC failures and Delayed results due to QC failures.
Cause as FDA categorized it: Under Investigation by firm
- One Step P in vitro diagnostic test REF: 8194Open, Classified
Z-2088-2026 · Started Apr 2, 2026 · Posted by FDA May 6, 2026
Reason given: The devices were distributed without required FDA premarket clearance or approval.
Cause as FDA categorized it: No Marketing Application
- Atellica CH Urine Albumin (UAlb). Material Number: 11537225Open, Classified
Siemens Healthcare Diagnostics, Inc.
Z-1484-2026 · Started Jan 20, 2026 · Posted by FDA Mar 2, 2026
Reason given: Falsely depressed UAlb patient results may occur. Affected samples with any urine albumin concentration above the UAlb measuring interval >40.0 mg/dL may report values between 6.2 mg/dL and 40.0 mg/dL.
Cause as FDA categorized it: Under Investigation by firm
4 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.